190 related articles for article (PubMed ID: 28465312)
1. A comparative analysis of whole genome sequencing of esophageal adenocarcinoma pre- and post-chemotherapy.
Noorani A; Bornschein J; Lynch AG; Secrier M; Achilleos A; Eldridge M; Bower L; Weaver JMJ; Crawte J; Ong CA; Shannon N; MacRae S; Grehan N; Nutzinger B; O'Donovan M; Hardwick R; Tavaré S; Fitzgerald RC;
Genome Res; 2017 Jun; 27(6):902-912. PubMed ID: 28465312
[TBL] [Abstract][Full Text] [Related]
2. Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy.
Findlay JM; Castro-Giner F; Makino S; Rayner E; Kartsonaki C; Cross W; Kovac M; Ulahannan D; Palles C; Gillies RS; MacGregor TP; Church D; Maynard ND; Buffa F; Cazier JB; Graham TA; Wang LM; Sharma RA; Middleton M; Tomlinson I
Nat Commun; 2016 Apr; 7():11111. PubMed ID: 27045317
[TBL] [Abstract][Full Text] [Related]
3. Tracking the genomic evolution of esophageal adenocarcinoma through neoadjuvant chemotherapy.
Murugaesu N; Wilson GA; Birkbak NJ; Watkins T; McGranahan N; Kumar S; Abbassi-Ghadi N; Salm M; Mitter R; Horswell S; Rowan A; Phillimore B; Biggs J; Begum S; Matthews N; Hochhauser D; Hanna GB; Swanton C
Cancer Discov; 2015 Aug; 5(8):821-831. PubMed ID: 26003801
[TBL] [Abstract][Full Text] [Related]
4. Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma.
Obulkasim A; Ylstra B; van Essen HF; Benner C; Stenning S; Langley R; Allum W; Cunningham D; Inam I; Hewitt LC; West NP; Meijer GA; van de Wiel MA; Grabsch HI
Oncotarget; 2016 Jul; 7(28):44084-44095. PubMed ID: 27286451
[TBL] [Abstract][Full Text] [Related]
5. Copy number alterations detected by whole-exome and whole-genome sequencing of esophageal adenocarcinoma.
Wang X; Li X; Cheng Y; Sun X; Sun X; Self S; Kooperberg C; Dai JY
Hum Genomics; 2015 Sep; 9(1):22. PubMed ID: 26374103
[TBL] [Abstract][Full Text] [Related]
6. Whole genome expression array profiling highlights differences in mucosal defense genes in Barrett's esophagus and esophageal adenocarcinoma.
Nancarrow DJ; Clouston AD; Smithers BM; Gotley DC; Drew PA; Watson DI; Tyagi S; Hayward NK; Whiteman DC; ;
PLoS One; 2011; 6(7):e22513. PubMed ID: 21829465
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal abnormalities and novel disease-related regions in progression from Barrett's esophagus to esophageal adenocarcinoma.
Akagi T; Ito T; Kato M; Jin Z; Cheng Y; Kan T; Yamamoto G; Olaru A; Kawamata N; Boult J; Soukiasian HJ; Miller CW; Ogawa S; Meltzer SJ; Koeffler HP
Int J Cancer; 2009 Nov; 125(10):2349-59. PubMed ID: 19670330
[TBL] [Abstract][Full Text] [Related]
8. Loss of Bcl-2 expression in Barrett's dysplasia and adenocarcinoma is associated with tumor progression and worse survival but not with response to neoadjuvant chemoradiation.
Raouf AA; Evoy DA; Carton E; Mulligan E; Griffin MM; Reynolds JV
Dis Esophagus; 2003; 16(1):17-23. PubMed ID: 12581249
[TBL] [Abstract][Full Text] [Related]
9. Integrative analysis of array-comparative genomic hybridisation and matched gene expression profiling data reveals novel genes with prognostic significance in oesophageal adenocarcinoma.
Goh XY; Rees JR; Paterson AL; Chin SF; Marioni JC; Save V; O'Donovan M; Eijk PP; Alderson D; Ylstra B; Caldas C; Fitzgerald RC
Gut; 2011 Oct; 60(10):1317-26. PubMed ID: 21478220
[TBL] [Abstract][Full Text] [Related]
10. Whole-genome sequencing provides new insights into the clonal architecture of Barrett's esophagus and esophageal adenocarcinoma.
Ross-Innes CS; Becq J; Warren A; Cheetham RK; Northen H; O'Donovan M; Malhotra S; di Pietro M; Ivakhno S; He M; Weaver JMJ; Lynch AG; Kingsbury Z; Ross M; Humphray S; Bentley D; Fitzgerald RC
Nat Genet; 2015 Sep; 47(9):1038-1046. PubMed ID: 26192915
[TBL] [Abstract][Full Text] [Related]
11. Response prediction in patients with gastric and esophagogastric adenocarcinoma under neoadjuvant chemotherapy using targeted gene expression analysis and next-generation sequencing in pre-therapeutic biopsies.
Kleo K; Jovanovic VM; Arndold A; Lehmann A; Lammert H; Berg E; Harloff H; Treese C; Hummel M; Daum S
J Cancer Res Clin Oncol; 2023 Mar; 149(3):1049-1061. PubMed ID: 35246724
[TBL] [Abstract][Full Text] [Related]
12. The genomic landscape of oesophagogastric junctional adenocarcinoma.
Chong IY; Cunningham D; Barber LJ; Campbell J; Chen L; Kozarewa I; Fenwick K; Assiotis I; Guettler S; Garcia-Murillas I; Awan S; Lambros M; Starling N; Wotherspoon A; Stamp G; Gonzalez-de-Castro D; Benson M; Chau I; Hulkki S; Nohadani M; Eltahir Z; Lemnrau A; Orr N; Rao S; Lord CJ; Ashworth A
J Pathol; 2013 Nov; 231(3):301-10. PubMed ID: 24308032
[TBL] [Abstract][Full Text] [Related]
13. Genomic Landscape of Esophageal Squamous Cell Carcinoma in a Japanese Population.
Sawada G; Niida A; Uchi R; Hirata H; Shimamura T; Suzuki Y; Shiraishi Y; Chiba K; Imoto S; Takahashi Y; Iwaya T; Sudo T; Hayashi T; Takai H; Kawasaki Y; Matsukawa T; Eguchi H; Sugimachi K; Tanaka F; Suzuki H; Yamamoto K; Ishii H; Shimizu M; Yamazaki H; Yamazaki M; Tachimori Y; Kajiyama Y; Natsugoe S; Fujita H; Mafune K; Tanaka Y; Kelsell DP; Scott CA; Tsuji S; Yachida S; Shibata T; Sugano S; Doki Y; Akiyama T; Aburatani H; Ogawa S; Miyano S; Mori M; Mimori K
Gastroenterology; 2016 May; 150(5):1171-1182. PubMed ID: 26873401
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of p53 tumor suppressor gene mutations in adenocarcinoma in Barrett esophagus].
Schneider PM; Hölscher AH; Wegerer S; König U; Becker K; Siewert JR
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):495-9. PubMed ID: 14518305
[TBL] [Abstract][Full Text] [Related]
15. Barrett's esophagus: cancer and molecular biology.
Gibson MK; Dhaliwal AS; Clemons NJ; Phillips WA; Dvorak K; Tong D; Law S; Pirchi ED; Räsänen J; Krasna MJ; Parikh K; Krishnadath KK; Chen Y; Griffiths L; Colleypriest BJ; Farrant JM; Tosh D; Das KM; Bajpai M
Ann N Y Acad Sci; 2013 Oct; 1300():296-314. PubMed ID: 24117650
[TBL] [Abstract][Full Text] [Related]
16. Genetic Alterations in Esophageal Tissues From Squamous Dysplasia to Carcinoma.
Liu X; Zhang M; Ying S; Zhang C; Lin R; Zheng J; Zhang G; Tian D; Guo Y; Du C; Chen Y; Chen S; Su X; Ji J; Deng W; Li X; Qiu S; Yan R; Xu Z; Wang Y; Guo Y; Cui J; Zhuang S; Yu H; Zheng Q; Marom M; Sheng S; Zhang G; Hu S; Li R; Su M
Gastroenterology; 2017 Jul; 153(1):166-177. PubMed ID: 28365443
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.
Wang K; Johnson A; Ali SM; Klempner SJ; Bekaii-Saab T; Vacirca JL; Khaira D; Yelensky R; Chmielecki J; Elvin JA; Lipson D; Miller VA; Stephens PJ; Ross JS
Oncologist; 2015 Oct; 20(10):1132-9. PubMed ID: 26336083
[TBL] [Abstract][Full Text] [Related]
18. Impaired transforming growth factor beta signalling in Barrett's carcinogenesis due to frequent SMAD4 inactivation.
Onwuegbusi BA; Aitchison A; Chin SF; Kranjac T; Mills I; Huang Y; Lao-Sirieix P; Caldas C; Fitzgerald RC
Gut; 2006 Jun; 55(6):764-74. PubMed ID: 16368780
[TBL] [Abstract][Full Text] [Related]
19. Microarray-based response prediction in esophageal adenocarcinoma.
Schauer M; Janssen KP; Rimkus C; Raggi M; Feith M; Friess H; Theisen J
Clin Cancer Res; 2010 Jan; 16(1):330-7. PubMed ID: 20028767
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of survivin mRNA is associated with a favorable prognosis following neoadjuvant radiochemotherapy in esophageal cancer.
Warnecke-Eberz U; Hokita S; Xi H; Higashi H; Baldus SE; Metzger R; Brabender J; Bollschweiler E; Mueller RP; Dienes HP; Hoelscher AH; Schneider PM
Oncol Rep; 2005 Jun; 13(6):1241-6. PubMed ID: 15870949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
